Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Fouad T. Chebib's publication output changed over time?
ScholarIQpublication output · 2015–2025
Output declined50% over the shown period — from 2 works in 2015 to 1 in 2025.
2
1
3
1
1
1
1
1
1
201520162018201920202021202220232025
What are the most-cited papers on Fouad T. Chebib?
ScholarIQmost cited works
Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016
Fouad T. Chebib, Vicente E. Torres
American Journal of Kidney Diseases. 2015318 CitationsOPEN ACCESS
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
Fouad T. Chebib, Ronald D. Perrone, Arlene B. Chapman, Neera K. Dahl, Peter C. Harris, Michal Mrug, Reem A. Mustafa, Anjay Rastogi, Terry Watnick, Alan S.L. Yu, Vicente E. Torres
Journal of the American Society of Nephrology. 2018260 CitationsOPEN ACCESS
Vasopressin and disruption of calcium signalling in polycystic kidney disease
Fouad T. Chebib, Caroline R. Sussman, Xiaofang Wang, Peter C. Harris, Vicente E. Torres
Nature Reviews Nephrology. 2015140 CitationsOPEN ACCESS
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
Fouad T. Chebib, Vicente E. Torres
Clinical Journal of the American Society of Nephrology. 2018124 CitationsOPEN ACCESS
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
Marie E. Edwards, Fouad T. Chebib, María V. Irazabal, Troy G. Ofstie, Lisa A. Bungum, Andrew J. Metzger, Sarah R. Senum, Marie C. Hogan, Ziad Zoghby, Timothy L. Kline, Peter C. Harris, Frank S. Czerwiec, Vicente E. Torres
Clinical Journal of the American Society of Nephrology. 201895 CitationsOPEN ACCESS
Related on ScholarIQ
Mayo Clinic in Florida
Institution
Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016
Paper
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
Paper
Vasopressin and disruption of calcium signalling in polycystic kidney disease
Paper
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
Paper
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
Paper